Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04936854 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease

StatusRecruiting
PhasePhase 2
Started2023-01-01
View on ClinicalTrials.gov ↗

Amendment history

2025-09-19
Study Status v4
Primary completion date2026-01→2028-01
Completion date2026-05→2028-12
2023-03-02
Not Yet Recruiting→Recruiting Study Status, Oversight, Contacts/Locations v3
Trial statusNot Yet Recruiting→Recruiting
Study sites0→1
2022-03-18
Study Status v2
Start date2022-01-01→2023-01-01
2021-08-24
Study Status, Study Description v1
Study description+30 characters
[...] ugs, Sirolimus is associated few side effects at low doses. WeThe investigators are planning a comparative study of conventional treatment [...] Sirolimus, regarding clinical outcomes and adverse effects. WeThe investigators plan to include a total of 60 patients (30 in each group) w [...]
2021-06-16
Original filing
The purpose of this study is to determine whether Sirolimus is more effective and burdened with less side effects than conventional treatment with corticosteroids in patients with active thyroid eye disease.
Trial Details
NCT Number NCT04936854
Lead Sponsor Haukeland University Hospital
Conditions Thyroid-Associated Ophthalmopathy
Enrollment 60 participants
Start Date 2023-01-01
Primary Completion 2028-01 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2025-09-22